Ovarian cancer MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
T2:
T2:
relatively low signal intensity of the tumour wall
relatively low signal intensity of the tumour wall
a shading sign may be seen 3
a shading sign may be seen  


T1 C + (Gd): can show mild enhancement 3== References ==
T1 C + (Gd): can show mild enhancement  
 
Ovarian serous cystadenocarcinoma
 
MRI
 
MRI is the modality of choice in the characterisation of ovarian malignancy and in the detection of lymphatic, peritoneal, and distant metastases, both for preoperative planning and post treatment follow up.
 
The cystic components are high T2, low T1 signal, unless there has been intralesional haemorrage (c.f. mucinous cystadenocarcinoma, where there is typically slightly increased T1 signal of the cystic component)
 
Solid malignant components demonstrate intermediate T1 and T2 signal, restricted diffusion, and gadolinium enhancement.
 
DWI is useful for detection of distant metastases.
== References ==
{{reflist|2}}
{{reflist|2}}



Revision as of 19:26, 14 December 2015


Ovarian cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classifications

Pathophysiology

Causes of Ovarian cancer

Differentiating Ovarian cancer from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian cancer MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian cancer MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian cancer MRI

CDC on Ovarian cancer MRI

Ovarian cancer MRI in the news

Blogs on Ovarian cancer MRI

Directions to Hospitals Treating Ovarian cancer

Risk calculators and risk factors for Ovarian cancer MRI

Endometrioid carcinoma of the ovary

Pelvic MRI

Reported signal characteristics include

T2: relatively low signal intensity of the tumour wall a shading sign may be seen

T1 C + (Gd): can show mild enhancement

Ovarian serous cystadenocarcinoma

MRI

MRI is the modality of choice in the characterisation of ovarian malignancy and in the detection of lymphatic, peritoneal, and distant metastases, both for preoperative planning and post treatment follow up.

The cystic components are high T2, low T1 signal, unless there has been intralesional haemorrage (c.f. mucinous cystadenocarcinoma, where there is typically slightly increased T1 signal of the cystic component)

Solid malignant components demonstrate intermediate T1 and T2 signal, restricted diffusion, and gadolinium enhancement.

DWI is useful for detection of distant metastases.

References

Template:WH

Template:WS